These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14597364)

  • 1. Lip cancer treatment with high dose rate brachytherapy.
    Guinot JL; Arribas L; Chust ML; Mengual JL; García Miragall E; Carrascosa M; Escolar PP; Crispín V; Guardino C
    Radiother Oncol; 2003 Oct; 69(1):113-5. PubMed ID: 14597364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.
    Guinot JL; Arribas L; Tortajada MI; Crispín V; Carrascosa M; Santos M; Mut A; Vendrell JB; Pesudo C; Chust ML
    Brachytherapy; 2013; 12(6):528-34. PubMed ID: 23850275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose-rate versus low dose-rate brachytherapy for lip cancer.
    Ghadjar P; Bojaxhiu B; Simcock M; Terribilini D; Isaak B; Gut P; Wolfensberger P; Brömme JO; Geretschläger A; Behrensmeier F; Pica A; Aebersold DM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1205-12. PubMed ID: 22099044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
    Unetsubo T; Matsuzaki H; Takemoto M; Katsui K; Hara M; Katayama N; Waki T; Kanazawa S; Asaumi J
    Radiat Oncol; 2015 Apr; 10():81. PubMed ID: 25888772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose rate brachytherapy in early stage squamous-cell carcinoma of the lip.
    Mut A; Guinot JL; Arribas L; Díez-Presa L; Tortajada MI; Santos MÁ; Samper J; Santamaría P; Vendrell JB
    Acta Otorrinolaringol Esp; 2016; 67(5):282-7. PubMed ID: 27063585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in squamous cell lip carcinoma treated with high-dose-rate brachytherapy.
    Guinot JL; Arribas L; Vendrell JB; Santos M; Tortajada MI; Mut A; Cruz J; Mengual JL; Chust ML
    Head Neck; 2014 Dec; 36(12):1737-42. PubMed ID: 24478179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
    Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
    Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacer.
    Masui K; Yamazaki H; Suzuki G; Shimizu D; Kawabata K; Noguchi N; Takenaka T; Yoshida K; Murakami N; Naito M; Yamamoto T; Kanamura N; Komori S; Oshita A; Asai J; Yamada K
    J Radiat Res; 2020 May; 61(3):506-510. PubMed ID: 32266411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
    Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
    Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachytherapy in lip carcinoma: long-term results.
    Guibert M; David I; Vergez S; Rives M; Filleron T; Bonnet J; Delannes M
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e839-43. PubMed ID: 21163589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interstitial brachytherapy in carcinoma of the lip. Case histories and results].
    Fongione S; Signor M; Beorchia A
    Radiol Med; 1994 Nov; 88(5):657-60. PubMed ID: 7824784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose rate brachytherapy in lip carcinoma.
    Conill C; Verger E; Marruecos J; Vargas M; Biete A
    Clin Transl Oncol; 2007 Apr; 9(4):251-4. PubMed ID: 17462978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio.
    Lau HY; Hay JH; Flores AD; Threlfall WJ
    Radiother Oncol; 1996 Apr; 39(1):15-8. PubMed ID: 8735489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: a nonrandomized comparison of treatment results.
    Hsu WL; Wu CJ; Jen YM; Yen SH; Lin KT; Ger LP; Kim RY
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1425-31. PubMed ID: 7635783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel high dose rate lip brachytherapy technique to improve dose homogeneity and reduce toxicity by customized mold.
    Feldman J; Appelbaum L; Sela M; Voskoboinik N; Kadouri S; Weinberger J; Orion I; Meirovitz A
    Radiat Oncol; 2014 Dec; 9():271. PubMed ID: 25533624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.